登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《LANCET，3月13日，Did the hesitancy in declaring COVID-19 a pandemic reflect a need to redefine the term?》

  • 来源专题：COVID-19科研动态监测
  • 编译者： xuwenwhlib
  • 发布时间：2020-03-14

  • Did the hesitancy in declaring COVID-19 a pandemic reflect a need to redefine the term?

    Manfred S Green

    Published:March 13, 2020DOI:https://doi.org/10.1016/S0140-6736(20)30630-9

    WHO's declaration that the global spread of coronavirus disease 2019 (COVID-19) is a pandemic1 has contributed greatly to clearing up confusion in the terminology in the professional literature and the media. Discussions on when wide geographical spread of a disease becomes a pandemic tend to recur when the world is confronted with an emerging infectious disease.2, 3 The debate around the terminology used for COVID-19 raises two important questions. The first question is why there was reluctance to call the COVID-19 outbreak a pandemic, and the second question is whether the terminology is of any practical importance.

  • 原文来源：https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30630-9/fulltext
59浏览量
原文链接
相关报告

  • 《LANCET，3月13日，COVID-19, a pandemic or not?》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-14
    • COVID-19, a pandemic or not? The Lancet Infectious Diseases Published:March 13, 2020DOI:https://doi.org/10.1016/S1473-3099(20)30180-8 The current outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread, and as of March 11, 2020, it has reached 115 countries, with 119?239 cases and 4287 deaths. In January, WHO decided to define the outbreak of COVID-19 as a public health emergency of international concern, which triggered the release of funding and other resources. Despite SARS-CoV-2 now being present in every continent apart from Antartica, WHO remains reluctant to make the next step and call the outbreak a pandemic.
    46浏览量
    原文链接

  • 《LANCET，3月13日，COVID-19, ECMO, and lymphopenia: a word of caution》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-03-14
    • COVID-19, ECMO, and lymphopenia: a word of caution Brandon Michael Henry Published:March 13, 2020DOI:https://doi.org/10.1016/S2213-2600(20)30119-3 Extracorporeal membrane oxygenation (ECMO) can serve as life-saving rescue therapy for refractory respiratory failure in the setting of acute respiratory distress syndrome, such as that induced by coronavirus disease 2019 (COVID-19). In the study by Yang and colleagues,1 who compared clinical characteristics and outcomes in patients with severe COVID-19, five (83%) of six patients receiving ECMO died. Although this sample was small, and specific baseline characteristics and disease courses were almost unknown, it raises concerns about potential harms of ECMO therapy for COVID-19.
    19浏览量
    原文链接